Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 23 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Income Statement [Abstract]      
Revenues         
Expenses      
Compensation and related taxes 426,675 840,943 3,103,137
Consulting fees 45,224 1,829,423 2,087,368
Professional fees 158,472 262,739 673,189
General and administrative 84,006 124,469 401,493
Total operating expenses 714,377 3,057,574 6,265,187
Operating loss from continuing operations (714,377) (3,057,574) (6,265,187)
Other income (expenses)      
Other income    125,000 125,000
Realized loss other than temporary decline - available for sale       (112,500)
Interest expense (230)    (383)
Interest income 291    1,269
Total other income 61 125,000 13,386
Loss from continuing operations before provision for income taxes (714,316) (2,932,574) (6,251,801)
Provision for income taxes         
Loss from continuing operations (714,316) (2,932,574) (6,251,801)
Discontinued operations:      
Gain (loss) from discontinued operations, net of tax 108,780 (27,305) (1,401,365)
Net loss (605,536) (2,959,879) (7,653,166)
Less: Net loss attributable to non-controlling interest       10,496
Net loss attributable to Marathon Patent Group, Inc. $ (605,536) $ (2,959,879) $ (7,642,670)
Loss per common share, basic and diluted:      
Loss from continuing operations $ (0.02) $ (0.09) $ (0.22)
Loss from discontinued operations $ 0.00 $ 0.00 $ (0.05)
Income Loss From Operations Basic And Diluted $ (0.01) $ (0.09) $ (0.27)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - Basic and Diluted 45,546,345 32,894,061 28,225,822